Crohn Disease Clinical Trials in Oklahoma City, Oklahoma

4 studies are recruiting for crohn disease in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Digestive Disease Specialists Inc, Oklahoma City, Oklahoma
    Locations
    370 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196722 on ClinicalTrials.gov

  2. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Digestive Disease Specialists Inc, Oklahoma City, Oklahoma
    Locations
    160 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07499232 on ClinicalTrials.gov

  3. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive [worsens with time] and life-threatening disease of the intesti…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Digestive Disease Specialists Inc, Oklahoma City, Oklahoma
    Locations
    142 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07577843 on ClinicalTrials.gov

  4. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ul…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Hightower Clinical, Oklahoma City, Oklahoma
    Locations
    24 in total
    Run by
    Mayo Clinic

    See if you can join NCT05230173 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.